Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018012617> ?p ?o ?g. }
- W2018012617 endingPage "1167" @default.
- W2018012617 startingPage "1159" @default.
- W2018012617 abstract "In order to select a better prostate cancer cell model for androgen receptor (AR)-mediated reporter gene assays, we assessed the androgen response characteristics of three cell lines, LNCaP, PC3/AR+ and 22Rv1, in this study. Both the mRNA and the proteins of AR and glucocorticoid receptor (GR) were expressed in all three cell lines. Among the three cell lines, only in LNCaP cells, DHT concentration-dependently stimulated proliferation. DHT induced the luciferase activity in three cell lines which were transiently transfected with pMMTV-Luc, in a concentration-dependent manner. The maximum induction was 24.0-fold and 13.4-fold in 22Rv1 and in the LNCaP respectively. PC3/AR+ were more sensitive to respond to DHT at a minimal concentration of 10−12 M by 14.0-fold induction. The transcriptional activity induced with 10−8 M DHT was inhibited about 50–75% in the PC3/AR+ and 22Rv1, and 98% in the LNCaP, by vinclozolin. Dexamethasone concentration-dependently induced the luciferase activity in PC3 and 22Rv1, but not in the LNCaP. However, the response to dexamethasone in 22Rv1 was very weak compared to DHT. The (anti)androgencity of seven pyrethroids was assessed via an AR-mediated luciferase reporter assay. None of them showed the androgenic action in all three cell lines. Permethrin inhibited the DHT induced luciferase activity about 22%, 35.8% and 75.5% in 22Rv1, PC3/AR+ and LNCaP, respectively. Based on results from in this study and cell line character, 22Rv1 cells seemed to be an appropriate model for the screening of androgenic endocrine disruptors, although it needs further studies with other steroid receptor and thyroid receptor." @default.
- W2018012617 created "2016-06-24" @default.
- W2018012617 creator A5027524889 @default.
- W2018012617 creator A5062990088 @default.
- W2018012617 creator A5075548073 @default.
- W2018012617 date "2006-10-01" @default.
- W2018012617 modified "2023-10-12" @default.
- W2018012617 title "Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays" @default.
- W2018012617 cites W1493920337 @default.
- W2018012617 cites W1984253914 @default.
- W2018012617 cites W1985120389 @default.
- W2018012617 cites W1985731718 @default.
- W2018012617 cites W1986296716 @default.
- W2018012617 cites W1987623753 @default.
- W2018012617 cites W1989978066 @default.
- W2018012617 cites W1990287298 @default.
- W2018012617 cites W2006112787 @default.
- W2018012617 cites W2014181668 @default.
- W2018012617 cites W2020215852 @default.
- W2018012617 cites W2021011470 @default.
- W2018012617 cites W2023704290 @default.
- W2018012617 cites W2037815393 @default.
- W2018012617 cites W2038052756 @default.
- W2018012617 cites W2049258047 @default.
- W2018012617 cites W2051552470 @default.
- W2018012617 cites W205313094 @default.
- W2018012617 cites W2066321889 @default.
- W2018012617 cites W2066570340 @default.
- W2018012617 cites W2071262171 @default.
- W2018012617 cites W2075882999 @default.
- W2018012617 cites W2083769456 @default.
- W2018012617 cites W2108835773 @default.
- W2018012617 cites W2119816167 @default.
- W2018012617 cites W2120798598 @default.
- W2018012617 cites W2124933025 @default.
- W2018012617 cites W2126058388 @default.
- W2018012617 cites W2130235559 @default.
- W2018012617 cites W2132078271 @default.
- W2018012617 cites W2137330819 @default.
- W2018012617 cites W2160670261 @default.
- W2018012617 cites W2167782130 @default.
- W2018012617 cites W2168787849 @default.
- W2018012617 cites W4249927795 @default.
- W2018012617 doi "https://doi.org/10.1016/j.tiv.2006.03.003" @default.
- W2018012617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16621434" @default.
- W2018012617 hasPublicationYear "2006" @default.
- W2018012617 type Work @default.
- W2018012617 sameAs 2018012617 @default.
- W2018012617 citedByCount "32" @default.
- W2018012617 countsByYear W20180126172012 @default.
- W2018012617 countsByYear W20180126172013 @default.
- W2018012617 countsByYear W20180126172014 @default.
- W2018012617 countsByYear W20180126172015 @default.
- W2018012617 countsByYear W20180126172016 @default.
- W2018012617 countsByYear W20180126172017 @default.
- W2018012617 countsByYear W20180126172018 @default.
- W2018012617 countsByYear W20180126172019 @default.
- W2018012617 countsByYear W20180126172020 @default.
- W2018012617 countsByYear W20180126172021 @default.
- W2018012617 countsByYear W20180126172022 @default.
- W2018012617 countsByYear W20180126172023 @default.
- W2018012617 crossrefType "journal-article" @default.
- W2018012617 hasAuthorship W2018012617A5027524889 @default.
- W2018012617 hasAuthorship W2018012617A5062990088 @default.
- W2018012617 hasAuthorship W2018012617A5075548073 @default.
- W2018012617 hasConcept C104317684 @default.
- W2018012617 hasConcept C111335760 @default.
- W2018012617 hasConcept C121608353 @default.
- W2018012617 hasConcept C126322002 @default.
- W2018012617 hasConcept C150194340 @default.
- W2018012617 hasConcept C161733203 @default.
- W2018012617 hasConcept C170493617 @default.
- W2018012617 hasConcept C185592680 @default.
- W2018012617 hasConcept C2779723316 @default.
- W2018012617 hasConcept C2780192828 @default.
- W2018012617 hasConcept C502942594 @default.
- W2018012617 hasConcept C54009773 @default.
- W2018012617 hasConcept C54355233 @default.
- W2018012617 hasConcept C55493867 @default.
- W2018012617 hasConcept C59493245 @default.
- W2018012617 hasConcept C61367390 @default.
- W2018012617 hasConcept C62112901 @default.
- W2018012617 hasConcept C71924100 @default.
- W2018012617 hasConcept C81885089 @default.
- W2018012617 hasConcept C86803240 @default.
- W2018012617 hasConceptScore W2018012617C104317684 @default.
- W2018012617 hasConceptScore W2018012617C111335760 @default.
- W2018012617 hasConceptScore W2018012617C121608353 @default.
- W2018012617 hasConceptScore W2018012617C126322002 @default.
- W2018012617 hasConceptScore W2018012617C150194340 @default.
- W2018012617 hasConceptScore W2018012617C161733203 @default.
- W2018012617 hasConceptScore W2018012617C170493617 @default.
- W2018012617 hasConceptScore W2018012617C185592680 @default.
- W2018012617 hasConceptScore W2018012617C2779723316 @default.
- W2018012617 hasConceptScore W2018012617C2780192828 @default.
- W2018012617 hasConceptScore W2018012617C502942594 @default.
- W2018012617 hasConceptScore W2018012617C54009773 @default.
- W2018012617 hasConceptScore W2018012617C54355233 @default.